HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects.

Abstract
Infiltration of immune effector cells in tumors is critical for antitumor immune responses. However, what regulates immune cell infiltration of tumors remains to be identified. Stat3 is constitutively activated with high frequency in diverse cancers, promoting tumor cell growth and survival. Blocking Stat3 signaling in tumors in vivo results in tumor growth inhibition that involves killing of nontransfected tumor cells and infiltration of immune effector cells, suggesting that Stat3 activity in tumor cells might affect immune cell recruitment. However, dying tumor cells can also attract immune cells. In this study, we show in isogenic murine melanomas that natural Stat3 activity is associated with tumor growth and reduction of T cell infiltration. Blocking Stat3 signaling in the melanoma cells containing high Stat3 activity results in expression of multiple chemoattractants, leading to increased migration of lymphocytes, NK cells, neutrophils, and macrophages. In addition, blocking Stat3 triggers tumor cells to produce soluble factors capable of activating macrophage production of NO in vitro and in vivo. TNF-alpha and IFN-beta, which are secreted by Stat3-inhibited tumor cells, are able to activate macrophage NO production, whereas neutralizing TNF-alpha in the tumor supernatant from Stat3-blocked tumor cells abrogates nitrite production. Moreover, interrupting Stat3 signaling in tumor cells leads to macrophage-mediated, nitrite-dependent cytostatic activity against nontransduced tumor cells. These results suggest that tumor Stat3 activity affects recruitment of diverse immune effectors and it can be manipulated to activate the effector phase of innate immune responses.
AuthorsLyudmila Burdelya, Maciej Kujawski, Guilian Niu, Bin Zhong, Tianhong Wang, Shumin Zhang, Marcin Kortylewski, Kenneth Shain, Heidi Kay, Julie Djeu, William Dalton, Drew Pardoll, Sheng Wei, Hua Yu
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 174 Issue 7 Pg. 3925-31 (Apr 01 2005) ISSN: 0022-1767 [Print] United States
PMID15778348 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Chemotactic Factors
  • DNA-Binding Proteins
  • Neoplasm Proteins
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Stat3 protein, mouse
  • Trans-Activators
  • Nitric Oxide
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation
  • Chemotactic Factors (genetics)
  • Chemotaxis (immunology)
  • DNA-Binding Proteins (genetics, physiology)
  • Female
  • Humans
  • Immunity, Innate
  • Macrophages (metabolism)
  • Melanoma, Experimental (immunology, pathology)
  • Mice
  • Mice, Inbred Strains
  • Mice, Knockout
  • Neoplasm Proteins (genetics, physiology)
  • Nitric Oxide (biosynthesis)
  • STAT3 Transcription Factor
  • T-Lymphocytes (physiology)
  • Trans-Activators (genetics, physiology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: